Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease-Reference-Cited by-同舟云学术

Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease

Published:2014-09-11 Issue:1 Volume:168 Page:82-93
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Casper Corey¹,Teltsch Dana Y.²,Robinson Don³,Desrosiers Marie-Pierre⁴,Rotella Philip²,Dispenzieri Angela⁵,Qi Ming⁶,Habermann Thomas⁵,Reynolds Matthew W.²

Affiliation:

1. Fred Hutchinson Cancer Research Center; Seattle WA USA

2. Evidera; Lexington MA USA

3. Janssen Global Services; Raritan NJ USA

4. United BioSource Corporation; Dorval QC Canada

5. Mayo Clinic; Rochester MN USA

6. Janssen Research and Development; Spring House PA USA

Funder

Janssen Research and Development

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13111/fullpdf

Reference25 articles.

1. Pathology of systemic lupus erythematosus: the challenges ahead;Azevedo;Methods in Molecular Biology,2014

2. Brief communication: rituximab in HIV-associated multicentric Castleman disease;Bower;Annals of Internal Medicine,2007

3. Clinical features and outcome in HIV-associated multicentric Castleman's disease;Bower;Journal of Clinical Oncology,2011

4. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice;Brandt;The Journal of Clinical Investigation,1990

5. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care;Casper;British Journal of Haematology,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease;Blood;2019-04-18

2. Analysis of clinical characteristics and prognosis factors of 71 cases with HIV-negative Castleman’s disease: hypoproteinemia is an unfavorable prognostic factor which should be treated appropriately;Journal of Cancer Research and Clinical Oncology;2018-05-07

3. Clinical, laboratory and imaging findings in Castleman's disease – The subtype decides;Blood Reviews;2018-05

4. Plasma Cell Variant Multicentric Castleman Disease and Kaposi's Sarcoma in a Treatment-Naive HIV-Infected Patient;AIDS Research and Human Retroviruses;2018-02

5. Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients;Cancer Science;2017-12-28